MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.730
-0.190 (-6.51%)
At close: Mar 24, 2026, 4:00 PM EDT
2.800
+0.070 (2.56%)
After-hours: Mar 24, 2026, 7:52 PM EDT
MacroGenics Stock Forecast
Stock Price Forecast
The 5 analysts that cover MacroGenics stock have a consensus rating of "Hold" and an average price target of $3.40, which forecasts a 24.54% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $5.00.
Price Target: $3.40 (+24.54%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MacroGenics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $3 → $4 | Buy | Maintains | $3 → $4 | +46.52% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | -26.74% | Nov 3, 2025 |
| Barclays | Barclays | Buy Initiates $3 | Buy | Initiates | $3 | +9.89% | Sep 17, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +9.89% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +83.15% | May 14, 2025 |
Financial Forecast
Revenue This Year
62.88M
from 149.50M
Decreased by -57.94%
Revenue Next Year
73.03M
from 62.88M
Increased by 16.14%
EPS This Year
-1.95
from -1.18
EPS Next Year
-1.85
from -1.95
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 122.4M | 94.3M | |||
| Avg | 62.9M | 73.0M | |||
| Low | 10.8M | 58.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -18.1% | 49.9% | |||
| Avg | -57.9% | 16.1% | |||
| Low | -92.8% | -6.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.11 | -1.01 | |||
| Avg | -1.95 | -1.85 | |||
| Low | -2.65 | -3.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.